News & Events about Axogen Inc.
ALACHUA, Fla. and TAMPA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2022 revenue. Preliminary ...
Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including over 1,500 nerve repairs across 35 studiesALACHUA, Fla. and TAMPA, Fla., Jan. 05, 2023 (GLOBE ...
ALACHUA, Fla. and TAMPA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Bri Majsiak, a Resensation patient, has been selected to ride on the 2023 Donate...
StockNews.com upgraded shares of AxoGen (NASDAQ:AXGN Get Rating) from a hold rating to a buy rating in a report issued on Thursday morning. AxoGen Trading Down 3.7 % AXGN opened at $11.32 on Thursday. AxoGen has a 52 week low of $6.87 and a 52 week high of $16.02. The business has a fifty []
...
Exchange Traded Concepts LLC decreased its holdings in AxoGen, Inc. (NASDAQ:AXGN Get Rating) by 61.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 94,212 shares of the medical equipment providers stock after selling 151,117 shares during...